InvestorNewsBreaks – Knight Therapeutics Inc. (TSX: GUD) Repays Credit Facility Used to Fund Paladin Acquisition
June 22, 2026 — This article has been disseminated on behalf of Knight Therapeutics Inc. and may include paid advertising.
The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)June 22, 2026 — This article has been disseminated on behalf of Knight Therapeutics Inc. and may include paid advertising.
June 22, 2026 — This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced the filing of an updated National Instrument 43-101 technical report for its Ying Ag-Pb-Zn-Au Property in Henan Province, China.
June 22, 2026 — This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced a non-brokered private placement of 6,764,069 units priced at C$0.
June 22, 2026 — This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) announced the successful completion of a 300-gram scale-up batch of A83B4C63, the active pharmaceutical ingredient supporting its proprietary ONC010 drug candidate.
June 22, 2026 — VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity.
June 22, 2026 — The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common. HeartBeam announced the launch of a pilot study focused on evaluating its on-demand 12-lead ECG patch in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia.
June 22, 2026 — VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity.
June 22, 2026 — This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.
June 22, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced the appointment of Chad Levesque as president and a member of its board of directors, expanding the company’s leadership team as it advances commercial evaluation of its Natural Hydrogen assets in Saskatchewan.
June 18, 2026 — Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.
June 18, 2026 — Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.
June 18, 2026 — Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. A clinical-stage oncology company , Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is focused on advancing a new class of DNA Damage Response (“DDR”) therapies and developing artificial intelligence-driven precision oncology solutions.
June 18, 2026 — Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.
June 18, 2026 — CNW CurrenSees Exploring the policies, markets and global events influencing currencies and the movement of money worldwide Proposal would require payment stablecoin issuers to implement customer identification programs similar to those used by banks and broker-dealers Regulators seek comment on digital identity tools, verifiable credentials and stablecoin market structure Rule aims to strengthen anti-money-laundering safeguards and align stablecoin oversight with existing financial regulations June 18, 2026 – via CurrencyNewsWire — The Financial Crimes Enforcement Network (“FinCEN”), together with federal banking regulators, has proposed new customer identification program (“CIP”) requirements for payment stablecoin issuers, a move designed to bring portions of the rapidly growing stablecoin market under a regulatory framework similar to that applied to traditional financial institutions. Under the proposal, payment stablecoin issuers would be required to establish and maintain customer identification programs intended to verify customer identities and support anti-money-laundering and counter-terrorist financing efforts.
June 18, 2026 — FingerMotion (NASDAQ: FNGR) announced that it and BlueFlare Energy Solutions are in advanced discussions regarding commercial terms for the first of two proposed behind-the-meter AI compute projects identified under their previously announced memorandum of understanding. The initial project is a roughly 600-kilowatt Alberta facility that currently uses natural gas that would otherwise be flared to power bitcoin mining operations, with plans to redevelop the site into an AI inference facility supported by new on-site power generation, battery energy storage and high-performance computing infrastructure.
June 18, 2026 — LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced that its previously disclosed acquisition of NOMAD Transportable Power Systems is expected to close on or about July 1, 2026, subject to customary conditions and approvals. Ahead of closing, LIXTE will provide a $6.
June 18, 2026 — Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused on various aspects of the healthcare industry, reflects management’s growing internal confidence in the company’s future trajectory. Over 3 million shares of common stock have been repurchased in current fiscal quarter, a significant acceleration in buybacks.
June 18, 2026 — Wearable Devices (NASDAQ: WLDS) announced that Founder and Chief Scientific Officer Guy Wagner will deliver a keynote presentation at AWE USA 2026 in Long Beach, California, titled “How BCI is Removing the Friction from AR and AI Interaction. ” The session will explore how brain-computer interface technologies, including wrist-worn neural sensing combined with biosignals such as inertial measurement unit and photoplethysmography data, can help bridge the gap between human intent and machine understanding in artificial intelligence and augmented reality environments.
June 18, 2026 — Earth Science Tech (OTC: ETST) reported financial results for the fiscal year ended March 31, 2026, highlighted by revenue of $35. 7 million, up 8% from the prior year, gross profit of $25.
June 18, 2026 — American Fusion (OTC: AMFN) announced that members of its engineering and leadership teams have arrived in Texas to accept delivery of the company’s 5MW Pre-Production Texatron Fusion Engine, a milestone that follows the completion of final fabrication and modification activities. The system is expected to be transported to the Dallas-Fort Worth Metroplex, where installation, commissioning and testing activities are planned as the company advances development of its proprietary aneutronic fusion technology.